MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

10 Hot Devices We Can't Get in the U.S.—NeoChord DS1000

10 Hot Devices We Can't Get in the U.S.—NeoChord DS1000

NeoChord's DS1000

NeoChord has developed the DS1000 for minimally-invasive mitral valve repair in patients suffering from severe mitral valve regurgitation.

Transapical transcatheter mitral valve repair with the DS1000 reduces the necessary incision from 3–10 inches to 2–3 inches and allows the procedure to be done off pump, according to information on the NeoChord Web site. This means the patient's heart continues beating during the procedure, as opposed to being stopped and put on cardio-pulmonary bypass.

The DS1000 received CE Mark in December 2012 but does not have FDA approval.


[Image courtesy of NEOCHORD]  

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.